Discover Community Create You

Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Article

Long non-coding RNAs towards precision medicine in gastric cancer: early diagnosis, treatment, and drug resistance

27 May 2020

Abstract excerpt

Gastric cancer is a deadly disease and remains the third leading cause of cancer-related death worldwide. The 5-year overall survival rate of patients with early-stage localized gastric cancer is more than 60%, whereas that of patients with distant metastasis is less than 5%. Surgical resection is the best option for early-stage gastric cancer, while chemotherapy is mainly used in the middle and advanced stages...

Read the complete abstract on PubMed

Topics

Share this publication in a Topic to start or enrich a Post.

Share to Cancer-related molecular mechanisms research
Share to Cholangiocarcinoma and Gallbladder Cancer Studies
Share to RNA modifications and cancer

Methodology Data sources Editorial policy Privacy About Contact Helena Bioinformatics

Source

Identifiers

PMID: 32460771
DOI: 10.1186/s12943-020-01219-0

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 8 Sept 2026.

Related research

Semantic proximity does not establish scientific evidence.

Research trail→

Click a neighbor to travelStep 1 · 12 closest

Long non-coding RNAs towards precision medicine in gastric cancer: early diagnosis, treatment, and drug resistancePMID 32460771Read ↗

Long noncoding RNAs as potential biomarkers in gastric cancer: Opportunities and challenges.Semantic proximity Read ↗

Long noncoding RNAs in gastric cancer: From molecular dissection to clinical applicationSemantic proximity Read ↗

The landscape of lncRNAs in gastric cancer: from molecular mechanisms to potential clinical applicationsSemantic proximity Read ↗

Long non-coding RNAs in gastric cancer: New emerging biological functions and therapeutic implicationsSemantic proximity Read ↗

Emerging role of long non-coding RNA in the development of gastric cancerSemantic proximity Read ↗

Long Non-Coding RNAs (lncRNAs) as Regulators of the PI3K/AKT/mTOR Pathway in Gastric CarcinomaSemantic proximity Read ↗

Long Non-Coding RNA in Gastric Cancer: Mechanisms and Clinical Implications for Drug ResistanceSemantic proximity Read ↗

Long noncoding RNAs as auxiliary biomarkers for gastric cancer screening: A pooled analysis of individual studiesSemantic proximity Read ↗

Roles of long noncoding RNAs in gastric cancer and their clinical applicationsSemantic proximity Read ↗

The prognostic, diagnostic, and therapeutic impact of Long noncoding RNAs in gastric cancerSemantic proximity Read ↗

A liquid biopsy signature of circulating exosome-derived mRNAs, miRNAs and lncRNAs predict therapeutic efficacy to neoadjuvant chemotherapy in patients with advanced gastric cancerSemantic proximity Read ↗

Long Non-Coding RNAs in Drug Resistance of Gastric Cancer: Complex Mechanisms and Potential Clinical ApplicationsSemantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.